SAN FRANCISCO, April 15, 2018 /PRNewswire/ — Nektar Therapeutics (Nasdaq: NKTR) today announced that it is presenting new preclinical data for its immuno-oncology programs at the American Association for Cancer Research (AACR) Annual Meeting 2018. Nektar researchers and collaborator…
Nektar Therapeutics Presents New Preclinical Data for its Immuno-Oncology Programs at the American Association for Cancer Research (AACR) Annual Meeting 2018
by Market News | Apr 15, 2018 | Blog